Exact Mass: 415.2206
Exact Mass Matches: 415.2206
Found 500 metabolites which its exact mass value is equals to given mass value 415.2206
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
CID 9844747
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Flesinoxan is a hypotensive agent and a potent, high affinity and selective 5-hydroxytryptamine1A (5-HT1A) receptor agonist with an EC50 value of 24 nM. Flesinoxan also has effective anxiolytic/antidepressant effects[1][2][3].
(2S)-2-[[(2S)-2-Amino-3-(1H-imidazol-5-yl)propanoyl]-(2-benzamidoethyl)amino]-4-methylpentanoic acid
Protostemotinine
Protostemotinine is a natural product found in Stemona sessilifolia, Stemona kerrii, and Stemona japonica with data available. Protostemotinine is an alkaloid isolated from the roots and rhizomes of Stemona sessilifolia. Protostemotinine is an alkaloid isolated from the roots and rhizomes of Stemona sessilifolia.
3-benzhydryloxy-1-[2-(1,3-benzodioxol-5-yl)ethyl]piperidine
AM toxin-II|Am-II-Toxin|AM-toxin II|N-(L-2-hydroxy-3-methyl-butyryl)-5-phenyl-L-norvalyl->2,3-didehydro-alanyl->L-alanine lactone|toxin II (Alternaria mali)
zamifenacin
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent CONFIDENCE standard compound; INTERNAL_ID 734; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8319; ORIGINAL_PRECURSOR_SCAN_NO 8318 CONFIDENCE standard compound; INTERNAL_ID 734; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8358; ORIGINAL_PRECURSOR_SCAN_NO 8357 CONFIDENCE standard compound; INTERNAL_ID 734; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8363; ORIGINAL_PRECURSOR_SCAN_NO 8361 CONFIDENCE standard compound; INTERNAL_ID 734; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8403; ORIGINAL_PRECURSOR_SCAN_NO 8402 CONFIDENCE standard compound; INTERNAL_ID 734; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8404; ORIGINAL_PRECURSOR_SCAN_NO 8402 CONFIDENCE standard compound; INTERNAL_ID 734; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8409; ORIGINAL_PRECURSOR_SCAN_NO 8407 Zamifenacin (UK-76654) is a potent gut-selective muscarinic M3 receptor antagonist. Zamifenacin significantly reduces colonic motility in irritable bowel syndrome[1].
Ala Ile Asn Val
Ala Ile Val Asn
Ala Lys Pro Thr
Ala Lys Thr Pro
Ala Leu Asn Val
Ala Leu Val Asn
Ala Asn Ile Val
Ala Asn Leu Val
Ala Asn Val Ile
Ala Asn Val Leu
Ala Pro Lys Thr
Ala Pro Gln Thr
Ala Pro Thr Lys
Ala Pro Thr Gln
Ala Gln Pro Thr
Ala Gln Thr Pro
Ala Gln Val Val
Ala Thr Lys Pro
Ala Thr Pro Lys
Ala Thr Pro Gln
Ala Thr Gln Pro
Ala Val Ile Asn
Ala Val Leu Asn
Ala Val Asn Ile
Ala Val Asn Leu
Ala Val Gln Val
Ala Val Val Gln
Asp Gly Lys Pro
Asp Gly Pro Lys
Asp Lys Gly Pro
Asp Lys Pro Gly
Asp Pro Gly Lys
Asp Pro Lys Gly
Gly Asp Lys Pro
Gly Asp Pro Lys
Gly Ile Ile Asn
Gly Ile Leu Asn
Gly Ile Asn Ile
Gly Ile Asn Leu
Gly Ile Gln Val
Gly Ile Val Gln
Gly Lys Asp Pro
Gly Lys Pro Asp
Gly Leu Ile Asn
Gly Leu Leu Asn
Gly Leu Asn Ile
Gly Leu Asn Leu
Gly Leu Gln Val
Gly Leu Val Gln
Gly Asn Ile Ile
Gly Asn Ile Leu
Gly Asn Leu Ile
Gly Asn Leu Leu
Gly Pro Asp Lys
Gly Pro Lys Asp
Gly Pro Arg Ser
Gly Pro Ser Arg
Gly Gln Ile Val
Gly Gln Leu Val
Gly Gln Val Ile
Gly Gln Val Leu
Gly Arg Pro Ser
Gly Arg Ser Pro
Gly Ser Pro Arg
Gly Ser Arg Pro
Gly Val Ile Gln
Gly Val Leu Gln
Gly Val Gln Ile
Gly Val Gln Leu
Ile Ala Asn Val
Ile Ala Val Asn
Ile Gly Ile Asn
Ile Gly Leu Asn
Ile Gly Asn Ile
Ile Gly Asn Leu
Ile Gly Gln Val
Ile Gly Val Gln
Ile Ile Gly Asn
Ile Ile Asn Gly
Ile Leu Gly Asn
Ile Leu Asn Gly
Ile Asn Ala Val
Ile Asn Gly Ile
Ile Asn Gly Leu
Ile Asn Ile Gly
Ile Asn Leu Gly
Ile Asn Val Ala
Ile Gln Gly Val
Ile Gln Val Gly
Ile Val Ala Asn
Ile Val Gly Gln
Ile Val Asn Ala
Ile Val Gln Gly
Lys Ala Pro Thr
Lys Ala Thr Pro
Lys Asp Gly Pro
Lys Asp Pro Gly
Lys Gly Asp Pro
Lys Gly Pro Asp
Lys Pro Ala Thr
Lys Pro Asp Gly
Lys Pro Gly Asp
Lys Pro Thr Ala
Lys Thr Ala Pro
Lys Thr Pro Ala
Leu Ala Asn Val
Leu Ala Val Asn
Leu Gly Ile Asn
Leu Gly Leu Asn
Leu Gly Asn Ile
Leu Gly Asn Leu
Leu Gly Gln Val
Leu Gly Val Gln
Leu Ile Gly Asn
Leu Ile Asn Gly
Leu Leu Gly Asn
Leu Leu Asn Gly
Leu Asn Ala Val
Leu Asn Gly Ile
Leu Asn Gly Leu
Leu Asn Ile Gly
Leu Asn Leu Gly
Leu Asn Val Ala
Leu Gln Gly Val
Leu Gln Val Gly
Leu Val Ala Asn
Leu Val Gly Gln
Leu Val Asn Ala
Leu Val Gln Gly
Asn Ala Ile Val
Asn Ala Leu Val
Asn Ala Val Ile
Asn Ala Val Leu
Asn Gly Ile Ile
Asn Gly Ile Leu
Asn Gly Leu Ile
Asn Gly Leu Leu
Asn Ile Ala Val
Asn Ile Gly Ile
Asn Ile Gly Leu
Asn Ile Ile Gly
Asn Ile Leu Gly
Asn Ile Val Ala
Asn Leu Ala Val
Asn Leu Gly Ile
Asn Leu Gly Leu
Asn Leu Ile Gly
Asn Leu Leu Gly
Asn Leu Val Ala
Asn Pro Ser Val
Asn Pro Val Ser
Asn Ser Pro Val
Asn Ser Val Pro
Asn Val Ala Ile
Asn Val Ala Leu
Asn Val Ile Ala
Asn Val Leu Ala
Asn Val Pro Ser
Asn Val Ser Pro
Pro Ala Lys Thr
Pro Ala Gln Thr
Pro Ala Thr Lys
Pro Ala Thr Gln
Pro Asp Gly Lys
Pro Asp Lys Gly
Pro Gly Asp Lys
Pro Gly Lys Asp
Pro Gly Arg Ser
Pro Gly Ser Arg
Pro Lys Ala Thr
Pro Lys Asp Gly
Pro Lys Gly Asp
Pro Lys Thr Ala
Pro Asn Ser Val
Pro Asn Val Ser
Pro Gln Ala Thr
Pro Gln Thr Ala
Pro Arg Gly Ser
Pro Arg Ser Gly
Pro Ser Gly Arg
Pro Ser Asn Val
Pro Ser Arg Gly
Pro Ser Val Asn
Pro Thr Ala Lys
Pro Thr Ala Gln
Pro Thr Lys Ala
Pro Thr Gln Ala
Pro Val Asn Ser
Pro Val Ser Asn
Gln Ala Pro Thr
Gln Ala Thr Pro
Gln Ala Val Val
Gln Gly Ile Val
Gln Gly Leu Val
Gln Gly Val Ile
Gln Gly Val Leu
Gln Ile Gly Val
Gln Ile Val Gly
Gln Leu Gly Val
Gln Leu Val Gly
Gln Pro Ala Thr
Gln Pro Thr Ala
Gln Thr Ala Pro
Gln Thr Pro Ala
Gln Val Ala Val
Gln Val Gly Ile
Gln Val Gly Leu
Gln Val Ile Gly
Gln Val Leu Gly
Gln Val Val Ala
Arg Gly Pro Ser
Arg Gly Ser Pro
Arg Pro Gly Ser
Arg Pro Ser Gly
Arg Ser Gly Pro
Arg Ser Pro Gly
Ser Gly Pro Arg
Ser Gly Arg Pro
Ser Asn Pro Val
Ser Asn Val Pro
Ser Pro Gly Arg
Ser Pro Asn Val
Ser Pro Arg Gly
Ser Pro Val Asn
Ser Arg Gly Pro
Ser Arg Pro Gly
Ser Val Asn Pro
Ser Val Pro Asn
Thr Ala Lys Pro
Thr Ala Pro Lys
Thr Ala Pro Gln
Thr Ala Gln Pro
Thr Lys Ala Pro
Thr Lys Pro Ala
Thr Pro Ala Lys
Thr Pro Ala Gln
Thr Pro Lys Ala
Thr Pro Gln Ala
Thr Gln Ala Pro
Thr Gln Pro Ala
Val Ala Ile Asn
Val Ala Leu Asn
Val Ala Asn Ile
Val Ala Asn Leu
Val Ala Gln Val
Val Ala Val Gln
Val Gly Ile Gln
Val Gly Leu Gln
Val Gly Gln Ile
Val Gly Gln Leu
Val Ile Ala Asn
Val Ile Gly Gln
Val Ile Asn Ala
Val Ile Gln Gly
Val Leu Ala Asn
Val Leu Gly Gln
Val Leu Asn Ala
Val Leu Gln Gly
Val Asn Ala Ile
Val Asn Ala Leu
Val Asn Ile Ala
Val Asn Leu Ala
Val Asn Pro Ser
Val Asn Ser Pro
Val Pro Asn Ser
Val Pro Ser Asn
Val Gln Ala Val
Val Gln Gly Ile
Val Gln Gly Leu
Val Gln Ile Gly
Val Gln Leu Gly
Val Gln Val Ala
Val Ser Asn Pro
Val Ser Pro Asn
Val Val Ala Gln
Val Val Gln Ala
5,6-dimethoxy-2-methyl-3-[2-(4-phenyl-1-piperazinyl)ethyl]-1H-indole hydrochloride
Donepezil Hydrochloride
D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D002800 - Cholinesterase Inhibitors D002491 - Central Nervous System Agents > D018697 - Nootropic Agents C471 - Enzyme Inhibitor > C47792 - Acetylcholinesterase Inhibitor D004791 - Enzyme Inhibitors
3-phenylacrylic acid (2r,3s)-3-dibenzylamino-2-hydroxybutyl ester
Celiprolol HCl
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
(S)-2-(3-BENZOYLPHENYL)-N-(4-HYDROXYPHENETHYL)-N-ISOPROPYLPROPANAMIDE
1,11-bis(trimethoxysilyl)-4-oxa-8-azaundecan-6-ol,50 in methanol
(2R)-2-[4-[(4-chlorophenyl)methyl]-5-methyl-1,2,4-triazol-3-yl]-N-cycloheptylpyrrolidine-1-carboxamide
(S)-2-[2-[Bis(2-tolyl)phosphino]phenyl]-4-tert-butyl-4,5-dihydro-oxazole
N-(3,4-Diethyloxy)phenylethyl-3,4-diethyloxyphenyl acetamide
N-[(1S)-2-[(1S,3S,5S)-3-Cyano-2-azabicyclo[3.1.0]hex-2-yl]-1-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)-2-oxoethyl]carbamic acid 1,1-dimethylethyl ester
1-(phenylmethyl)-N-(2,4,6-trimethylphenyl)sulfonyl-4-piperidinecarbohydrazide
[1-acetyl-4-tert-butyl-3,6-bis(tert-butylsulfanyl)-3,6-dihydro-2H-pyridin-2-yl] acetate
1-{[(1E)-(3-Hydroxy-2-methyl-5-{[(trihydroxy-lambda^5^-phosphanyl)oxy]methyl}pyridin-4-YL)methylidene]amino}undecan-2-one
N-[[4-(2-propan-2-yl-5-pyridin-4-ylpyrimidin-4-yl)cyclohexyl]methyl]pyridine-3-carboxamide
17-O-deacetylvindolinium
A vinca alkaloid cation that is the conjugate acid of 17-O-deacetylvindoline.
(2S)-2-[[(2S)-2-Amino-3-(1H-imidazol-5-yl)propanoyl]-(2-benzamidoethyl)amino]-4-methylpentanoic acid
smenospongines C
A sesquiterpenoid isolated from the marine sponge Dactylospongia elegans.
3,6-Bis(dimethylamino)-9-(2-(ethoxycarbonyl)-phenyl)xanthylium
1-acetyl-N-[3-(N-ethyl-3-methylanilino)propyl]-2,3-dihydroindole-5-sulfonamide
1-(4-tert-butylphenyl)sulfonyl-N-(2-pyridinylmethyl)-2-piperidinecarboxamide
5-(Pentoxymethyl)-3-[(2E)-2-[(4-phenyl-1,3-thiazol-2-yl)hydrazinylidene]propyl]oxolan-2-one
(12R,15S,16R,8R)-15-methoxy-7,8,10-trimethyl-6,9-dioxo-13,14,15,16-tetrahydro-12H-4-oxa-7,10-diaza-1(2,6)-pyrana-5(1,2)-benzenacycloundecaphane-56-carbonitrile
(1R,4R,5R,5S,8S)-1-methyl-5-(2-methylpropyl)-4-[(2S)-3-oxobutan-2-yl]spiro[2-oxatricyclo[6.4.1.04,13]tridec-4(13)-ene-5,3-pyrrolidine]-2,3,6-trione
(1S,12R,17S,20S)-20-methoxy-11,12,14-trimethyl-10,13-dioxo-3,21-dioxa-11,14-diazatricyclo[15.3.1.04,9]henicosa-4,6,8-triene-5-carbonitrile
4-[(3aR,4R,9bR)-1-[cyclohexyl(oxo)methyl]-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-8-yl]benzonitrile
4-[(3aS,4R,9bS)-1-[cyclohexyl(oxo)methyl]-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-8-yl]benzonitrile
4-[(3aR,4S,9bR)-1-[cyclohexyl(oxo)methyl]-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-8-yl]benzonitrile
(1S,9R,10R,11R)-5-(cyclohexen-1-yl)-12-ethyl-10-(hydroxymethyl)-N-(2-methoxyethyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
(1R,9S,10S,11S)-5-(cyclohexen-1-yl)-12-ethyl-10-(hydroxymethyl)-N-(2-methoxyethyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
N-[[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(3-methylbut-1-ynyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylpropanamide
N-[[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-(3-methylbut-1-ynyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylpropanamide
(1S,13S,17R,18R)-18-methoxy-12,13,15-trimethyl-11,14-dioxo-4,21-dioxa-12,15-diazatricyclo[15.3.1.05,10]henicosa-5,7,9-triene-6-carbonitrile
(1S,13R,17R,18S)-18-methoxy-12,13,15-trimethyl-11,14-dioxo-4,21-dioxa-12,15-diazatricyclo[15.3.1.05,10]henicosa-5,7,9-triene-6-carbonitrile
(1S,13R,17S,18S)-18-methoxy-12,13,15-trimethyl-11,14-dioxo-4,21-dioxa-12,15-diazatricyclo[15.3.1.05,10]henicosa-5,7,9-triene-6-carbonitrile
(1R,13R,17R,18R)-18-methoxy-12,13,15-trimethyl-11,14-dioxo-4,21-dioxa-12,15-diazatricyclo[15.3.1.05,10]henicosa-5,7,9-triene-6-carbonitrile
(1R,13R,17S,18S)-18-methoxy-12,13,15-trimethyl-11,14-dioxo-4,21-dioxa-12,15-diazatricyclo[15.3.1.05,10]henicosa-5,7,9-triene-6-carbonitrile
(1S,13R,17S,18R)-18-methoxy-12,13,15-trimethyl-11,14-dioxo-4,21-dioxa-12,15-diazatricyclo[15.3.1.05,10]henicosa-5,7,9-triene-6-carbonitrile
(1R,13R,17R,18R)-18-methoxy-12,13,15-trimethyl-11,14-dioxo-4,21-dioxa-12,15-diazatricyclo[15.3.1.05,10]henicosa-5(10),6,8-triene-8-carbonitrile
(1S,13S,17R,18R)-18-methoxy-12,13,15-trimethyl-11,14-dioxo-4,21-dioxa-12,15-diazatricyclo[15.3.1.05,10]henicosa-5(10),6,8-triene-8-carbonitrile
(1S,13R,17S,18R)-18-methoxy-12,13,15-trimethyl-11,14-dioxo-4,21-dioxa-12,15-diazatricyclo[15.3.1.05,10]henicosa-5(10),6,8-triene-8-carbonitrile
(1R,13S,17R,18S)-18-methoxy-12,13,15-trimethyl-11,14-dioxo-4,21-dioxa-12,15-diazatricyclo[15.3.1.05,10]henicosa-5(10),6,8-triene-8-carbonitrile
(1S,13R,17R,18R)-18-methoxy-12,13,15-trimethyl-11,14-dioxo-4,21-dioxa-12,15-diazatricyclo[15.3.1.05,10]henicosa-5(10),6,8-triene-8-carbonitrile
(1R,12S,17S,20S)-20-methoxy-11,12,14-trimethyl-10,13-dioxo-3,21-dioxa-11,14-diazatricyclo[15.3.1.04,9]henicosa-4(9),5,7-triene-7-carbonitrile
(1S,12S,17R,20R)-20-methoxy-11,12,14-trimethyl-10,13-dioxo-3,21-dioxa-11,14-diazatricyclo[15.3.1.04,9]henicosa-4(9),5,7-triene-7-carbonitrile
(1R,12S,17R,20S)-20-methoxy-11,12,14-trimethyl-10,13-dioxo-3,21-dioxa-11,14-diazatricyclo[15.3.1.04,9]henicosa-4(9),5,7-triene-7-carbonitrile
(1R,12S,17R,20R)-20-methoxy-11,12,14-trimethyl-10,13-dioxo-3,21-dioxa-11,14-diazatricyclo[15.3.1.04,9]henicosa-4(9),5,7-triene-7-carbonitrile
(1S,12S,17S,20S)-20-methoxy-11,12,14-trimethyl-10,13-dioxo-3,21-dioxa-11,14-diazatricyclo[15.3.1.04,9]henicosa-4(9),5,7-triene-7-carbonitrile
(1R,12R,17S,20R)-20-methoxy-11,12,14-trimethyl-10,13-dioxo-3,21-dioxa-11,14-diazatricyclo[15.3.1.04,9]henicosa-4,6,8-triene-5-carbonitrile
(1S,12S,17S,20R)-20-methoxy-11,12,14-trimethyl-10,13-dioxo-3,21-dioxa-11,14-diazatricyclo[15.3.1.04,9]henicosa-4,6,8-triene-5-carbonitrile
(1R,12R,17R,20S)-20-methoxy-11,12,14-trimethyl-10,13-dioxo-3,21-dioxa-11,14-diazatricyclo[15.3.1.04,9]henicosa-4,6,8-triene-5-carbonitrile
(1S,12R,17S,20R)-20-methoxy-11,12,14-trimethyl-10,13-dioxo-3,21-dioxa-11,14-diazatricyclo[15.3.1.04,9]henicosa-4,6,8-triene-5-carbonitrile
(1S,12R,17R,20S)-20-methoxy-11,12,14-trimethyl-10,13-dioxo-3,21-dioxa-11,14-diazatricyclo[15.3.1.04,9]henicosa-4,6,8-triene-5-carbonitrile
1-[(2R,3R)-6-[(2,5-difluorophenyl)methyl]-2-(hydroxymethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-1-yl]-2-(dimethylamino)ethanone
N-[[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-(3-methylbut-1-ynyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylpropanamide
N-[[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(3-methylbut-1-ynyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylpropanamide
N-[[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(3-methylbut-1-ynyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylpropanamide
N-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-(3-methylbut-1-ynyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylpropanamide
(1S,13S,17R,18S)-18-methoxy-12,13,15-trimethyl-11,14-dioxo-4,21-dioxa-12,15-diazatricyclo[15.3.1.05,10]henicosa-5,7,9-triene-6-carbonitrile
(1R,13S,17R,18S)-18-methoxy-12,13,15-trimethyl-11,14-dioxo-4,21-dioxa-12,15-diazatricyclo[15.3.1.05,10]henicosa-5,7,9-triene-6-carbonitrile
(1R,13S,17R,18R)-18-methoxy-12,13,15-trimethyl-11,14-dioxo-4,21-dioxa-12,15-diazatricyclo[15.3.1.05,10]henicosa-5,7,9-triene-6-carbonitrile
(1R,13R,17S,18R)-18-methoxy-12,13,15-trimethyl-11,14-dioxo-4,21-dioxa-12,15-diazatricyclo[15.3.1.05,10]henicosa-5,7,9-triene-6-carbonitrile
(1S,13S,17S,18R)-18-methoxy-12,13,15-trimethyl-11,14-dioxo-4,21-dioxa-12,15-diazatricyclo[15.3.1.05,10]henicosa-5,7,9-triene-6-carbonitrile
(1S,13S,17S,18S)-18-methoxy-12,13,15-trimethyl-11,14-dioxo-4,21-dioxa-12,15-diazatricyclo[15.3.1.05,10]henicosa-5,7,9-triene-6-carbonitrile
(1R,13S,17S,18R)-18-methoxy-12,13,15-trimethyl-11,14-dioxo-4,21-dioxa-12,15-diazatricyclo[15.3.1.05,10]henicosa-5,7,9-triene-6-carbonitrile
(1R,13R,17S,18S)-18-methoxy-12,13,15-trimethyl-11,14-dioxo-4,21-dioxa-12,15-diazatricyclo[15.3.1.05,10]henicosa-5(10),6,8-triene-8-carbonitrile
(1S,13S,17S,18S)-18-methoxy-12,13,15-trimethyl-11,14-dioxo-4,21-dioxa-12,15-diazatricyclo[15.3.1.05,10]henicosa-5(10),6,8-triene-8-carbonitrile
(1S,13S,17S,18R)-18-methoxy-12,13,15-trimethyl-11,14-dioxo-4,21-dioxa-12,15-diazatricyclo[15.3.1.05,10]henicosa-5(10),6,8-triene-8-carbonitrile
(1R,13R,17S,18R)-18-methoxy-12,13,15-trimethyl-11,14-dioxo-4,21-dioxa-12,15-diazatricyclo[15.3.1.05,10]henicosa-5(10),6,8-triene-8-carbonitrile
(1S,13S,17R,18S)-18-methoxy-12,13,15-trimethyl-11,14-dioxo-4,21-dioxa-12,15-diazatricyclo[15.3.1.05,10]henicosa-5(10),6,8-triene-8-carbonitrile
(1R,13S,17R,18R)-18-methoxy-12,13,15-trimethyl-11,14-dioxo-4,21-dioxa-12,15-diazatricyclo[15.3.1.05,10]henicosa-5(10),6,8-triene-8-carbonitrile
(1R,12S,17S,20R)-20-methoxy-11,12,14-trimethyl-10,13-dioxo-3,21-dioxa-11,14-diazatricyclo[15.3.1.04,9]henicosa-4(9),5,7-triene-7-carbonitrile
(1S,12R,17R,20S)-20-methoxy-11,12,14-trimethyl-10,13-dioxo-3,21-dioxa-11,14-diazatricyclo[15.3.1.04,9]henicosa-4(9),5,7-triene-7-carbonitrile
(1S,12R,17R,20R)-20-methoxy-11,12,14-trimethyl-10,13-dioxo-3,21-dioxa-11,14-diazatricyclo[15.3.1.04,9]henicosa-4(9),5,7-triene-7-carbonitrile
(1S,12S,17R,20S)-20-methoxy-11,12,14-trimethyl-10,13-dioxo-3,21-dioxa-11,14-diazatricyclo[15.3.1.04,9]henicosa-4(9),5,7-triene-7-carbonitrile
(1S,12R,17S,20R)-20-methoxy-11,12,14-trimethyl-10,13-dioxo-3,21-dioxa-11,14-diazatricyclo[15.3.1.04,9]henicosa-4(9),5,7-triene-7-carbonitrile
(1S,12S,17S,20R)-20-methoxy-11,12,14-trimethyl-10,13-dioxo-3,21-dioxa-11,14-diazatricyclo[15.3.1.04,9]henicosa-4(9),5,7-triene-7-carbonitrile
(1R,12R,17R,20S)-20-methoxy-11,12,14-trimethyl-10,13-dioxo-3,21-dioxa-11,14-diazatricyclo[15.3.1.04,9]henicosa-4(9),5,7-triene-7-carbonitrile
(1R,12R,17R,20R)-20-methoxy-11,12,14-trimethyl-10,13-dioxo-3,21-dioxa-11,14-diazatricyclo[15.3.1.04,9]henicosa-4(9),5,7-triene-7-carbonitrile
(1S,12R,17S,20S)-20-methoxy-11,12,14-trimethyl-10,13-dioxo-3,21-dioxa-11,14-diazatricyclo[15.3.1.04,9]henicosa-4(9),5,7-triene-7-carbonitrile
(1R,12R,17S,20S)-20-methoxy-11,12,14-trimethyl-10,13-dioxo-3,21-dioxa-11,14-diazatricyclo[15.3.1.04,9]henicosa-4(9),5,7-triene-7-carbonitrile
(1R,12R,17R,20R)-20-methoxy-11,12,14-trimethyl-10,13-dioxo-3,21-dioxa-11,14-diazatricyclo[15.3.1.04,9]henicosa-4,6,8-triene-5-carbonitrile
(1R,12R,17S,20S)-20-methoxy-11,12,14-trimethyl-10,13-dioxo-3,21-dioxa-11,14-diazatricyclo[15.3.1.04,9]henicosa-4,6,8-triene-5-carbonitrile
(1S,12S,17R,20R)-20-methoxy-11,12,14-trimethyl-10,13-dioxo-3,21-dioxa-11,14-diazatricyclo[15.3.1.04,9]henicosa-4,6,8-triene-5-carbonitrile
(1S,12S,17R,20S)-20-methoxy-11,12,14-trimethyl-10,13-dioxo-3,21-dioxa-11,14-diazatricyclo[15.3.1.04,9]henicosa-4,6,8-triene-5-carbonitrile
(1R,12S,17S,20S)-20-methoxy-11,12,14-trimethyl-10,13-dioxo-3,21-dioxa-11,14-diazatricyclo[15.3.1.04,9]henicosa-4,6,8-triene-5-carbonitrile
(1R,12S,17R,20R)-20-methoxy-11,12,14-trimethyl-10,13-dioxo-3,21-dioxa-11,14-diazatricyclo[15.3.1.04,9]henicosa-4,6,8-triene-5-carbonitrile
(1R,12S,17S,20R)-20-methoxy-11,12,14-trimethyl-10,13-dioxo-3,21-dioxa-11,14-diazatricyclo[15.3.1.04,9]henicosa-4,6,8-triene-5-carbonitrile
(1R,12S,17R,20S)-20-methoxy-11,12,14-trimethyl-10,13-dioxo-3,21-dioxa-11,14-diazatricyclo[15.3.1.04,9]henicosa-4,6,8-triene-5-carbonitrile
(1S,12R,17R,20R)-20-methoxy-11,12,14-trimethyl-10,13-dioxo-3,21-dioxa-11,14-diazatricyclo[15.3.1.04,9]henicosa-4,6,8-triene-5-carbonitrile
4-[(3aS,4S,9bS)-1-[cyclohexyl(oxo)methyl]-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-8-yl]benzonitrile
1-[(2S,3R)-6-[(2,5-difluorophenyl)methyl]-2-(hydroxymethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-1-yl]-2-(dimethylamino)ethanone
(2R,3R)-6-[(3,5-difluorophenyl)methyl]-2-(hydroxymethyl)-3-phenyl-N-propan-2-yl-1,6-diazaspiro[3.3]heptane-1-carboxamide
GSK163090
GSK163090 is a potent, selective and orally active 5-HT1A/1B/1D receptor antagonist with pKi values of 9.4/8.5/9.7, respectively. GSK163090 inhibits the functional activity of serotonin reuptake transporter (SerT) with a pKi value of 6.1. GSK163090 has antidepressant and anxiolytic activities[1].
Ninerafaxstat
Ninerafaxstat (IMB-1018972) is a novel mitotropic agent. Ninerafaxstat increases myocardial metabolic efficiency by shifting substrate utilization towards glucose through reducing fatty acid oxidation (inhibiting 3-ketoacyl CoA thiolase). Ninerafaxstat can be used for the research of cardiovascular diseases[1].